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Case 3-2017: A Man with Cardiac Sarcoidosis and New Diplopia 
and Weakness
To the Editor: In the Case Record discussed by 
Samuels et al. (Jan. 26 issue),1 the autopsy of the 
unfortunate patient who died of granulomatous 
amebic encephalitis revealed numerous perivas-
cular radiating hemorrhagic areas. This finding 
is typical in patients with meningoencephalitis 
caused by acanthamoeba species but unusual in 
patients with neurosarcoidosis, in whom intra-
cranial hemorrhages are extremely rare and if 
present are readily seen on computed tomogra-
phy (CT).2,3 The initial findings on CT and CT 
angiography of the head in the patient in this 
Case Record were reported to be normal.
An analytic sensitivity test to detect brain 
hemorrhages of any cause not found on CT is 
spectrophotometry.4 In the cerebrospinal fluid 
(CSF), bilirubin has a yellowish color commonly 
referred to as xanthochromia. A small amount of 
CSF bilirubin is easily missed by visual inspec-
tion.4 In the patient in this Case Record, the CSF 
was reported to be colorless, clear, and without 
xanthochromia on admission and on hospital 
days 5 and 6. The CSF was reported to be yellow 
only on hospital day 9. The interpretation of this 
finding as xanthochromia in the presence of an 
elevated level of CSF total protein is a common 
mistake.
Was CSF spectrophotometry performed in this 
patient? An early diagnosis of hemorrhagic menin-
goencephalitis, on the basis of findings on CSF 
spectrophotometry, would have narrowed the 
differential diagnosis at presentation and guided 
emergency management.
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Directors of the Massachusetts General 
Hospital Core Laboratory reply: CSF bilirubin 
concentrations typically become abnormally high 
within 12 hours after a subarachnoid hemorrhage. 
This elevation stems from the metabolism of 
heme contained within the hemorrhaged red cells.
As Petzold’s letter indicates, spectrophotom-
etry, a technique commonly used in some coun-
tries other than the United States,1 provides a 
sensitive method for detecting elevated concen-
trations of CSF bilirubin. Petzold further sug-
gests that spectrophotometry may have led to an 
earlier diagnosis in our patient. However, spec-
trophotometry was not performed, since our hos-
pital, like almost all other hospitals in the United 
States,2 does not offer this technique. Instead, 
our laboratory inspects CSF specimens visually 
for xanthochromia, a yellow color that suggests 
increased concentrations of bilirubin.
Spectrophotometry may provide greater analytic 
sensitivity than visual inspection to detect bilirubin 
at lower concentrations and greater analytic speci-
ficity to distinguish bilirubin from other substanc-
es.3,4 However, this advantage is potentially gained 
at the cost of reduced clinical specificity3,4 for diag-
nosing subarachnoid hemorrhage. The clinical 
value of CSF spectrophotometry and whether 
this technique should be more widely adopted in 
the United States remain topics of ongoing debate.
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